A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China
Abroad (travel likely)Recruiting
Conditions
Progressive Familial Intrahepatic Cholestasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Capital Children's Medical Center, Beijing, China
Hunan Children's Hospital, Hunan, China
Children's Hospital of Fudan University Endocrinology and Metabolism, Shanghai, China
Study leads
Ipsen Medical Director
Study Director
Ipsen